Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Stoke Therapeutics Inc shares valued at $769,500 were sold by Nash Huw M. on May 20 ’24. At $15.39 per share, Nash Huw M. sold 50,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kaye Edward M. MD sold 42,350 shares, netting a total of over 653,529 in proceeds. Following the sale of shares at $15.43 each, the insider now holds 27,000 shares.
Before that, Allan Jonathan had sold 8,599 shares from its account. In a trade valued at $129,327, the GENERAL COUNSEL & CORP SEC traded Stoke Therapeutics Inc shares for $15.04 each. Upon closing the transaction, the insider’s holdings decreased to 8,599 shares, worth approximately $35774.46.
As published in a research note from TD Cowen on March 26, 2024, Stoke Therapeutics Inc [STOK] has been rated up from a Market perform to an Outperform. As of July 25, 2023, TD Cowen has decreased its “an Outperform” rating to a “Market perform” for STOK. Earlier on May 01, 2023, BofA Securities upgraded its rating. Their new recommendation was “a Neutral” for STOK stock which previously was a “an Underperform”.
Analyzing STOK Stock Performance
During the last five days, there has been a drop of approximately -10.29%. Over the course of the year, Stoke Therapeutics Inc shares have jumped approximately 161.79%. Shares of the company reached a 52-week high of $16.66 on 05/22/24 and a 52-week low of $4.09 on 02/13/24. A 50-day SMA is recorded $12.07, while a 200-day SMA reached $6.73. Nevertheless, trading volume fell to 0.33 million shares from 0.46 million shares the previous day.
Support And Resistance Levels for Stoke Therapeutics Inc (STOK)
According to the 24-hour chart, there is a support level at 13.54, which, if violated, would cause prices to drop to 13.30. In the upper region, resistance lies at 14.01. The next price resistance is at 14.24. RSI (Relative Strength Index) is 54.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.22, which suggests the price will decrease in the coming days. Percent R is at 51.18%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
